SLB
41
2
ADM
39
3
AMG
36
-4
DIS
66
4
FE
50
-2
LNC
50
2
CFG
50
4
IRM
67
2
WFC
71
13
KHC
31
-3
MAR
48
3
BLK
67
4
NTAP
74
2
RRC
72
6
ORLY
58
2
FAST
45
-4
BK
72
3
SIG
72
2
WU
48
-4
UA
33
-2
SLB
41
2
ADM
39
3
AMG
36
-4
DIS
66
4
FE
50
-2
LNC
50
2
CFG
50
4
IRM
67
2
WFC
71
13
KHC
31
-3
MAR
48
3
BLK
67
4
NTAP
74
2
RRC
72
6
ORLY
58
2
FAST
45
-4
BK
72
3
SIG
72
2
WU
48
-4
UA
33
-2
Financhill
Back

4D Molecular Therapeutics Quote, Financials, Valuation and Earnings

MarketBeat Alert: Strong sell signal just issued for these 20 stocks

Go here now to get free instant access to all 20 stocks to sell.
Buy
55

FDMT
4D Molecular Therapeutics

Last Price:
26.82
Seasonality Move:
-18.33%

7 Day Trial

ALL ACCESS PASS

$ 7

9,530x the last time this happened

Here's what our expert says you should buy before April 14.

4D Molecular Therapeutics Price Quote

$26.82
+0.03 (+0.3%)
(Updated: May 8, 2024 at 4:09 AM ET)

4D Molecular Therapeutics Key Stats

Buy
55
4D Molecular Therapeutics (FDMT) is a Buy
Day range:
$26.26 - $27.09
52-week range:
$9.44 - $36.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
50.48
P/B ratio:
4.33%
Volume:
253.7K
Avg. volume:
593K
1-year change:
58.15%
Market cap:
$1.3B
Revenue:
$20.7M
EPS:
$-2.66

How Much Does 4D Molecular Therapeutics Make?

Is 4D Molecular Therapeutics Growing As A Company?

Data Unavailable

4D Molecular Therapeutics Stock Price Performance

What Is 4D Molecular Therapeutics 52-Week High & Low?

4D Molecular Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy 4D Molecular Therapeutics?

Is 4D Molecular Therapeutics Cash Flow Positive?

  • What Is FDMT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$75.8M
  • What Is 4D Molecular Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $156.8M
  • What Is 4D Molecular Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $115.7M

4D Molecular Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    FDMT return on invested capital is -35.69%
  • What Is 4D Molecular Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -32.32%
  • What Is FDMT Return On Equity?
    ROE is a measure of profitability and is -35.69%

4D Molecular Therapeutics Earnings Date & Stock Price

4D Molecular Therapeutics Competitors

4D Molecular Therapeutics Dividend Yield

Data Unavailable

4D Molecular Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -5.8%
Revenue: 0% -100.79%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 54.22
Upside from Last Price: 102.4%

Major Shareholders

  • How many FDMT shares are owned by institutional investors?
    65.9M FDMT shares are owned by institutional investors
  • How many FDMT shares are owned by insiders?
    2M FDMT shares are owned by insiders